MAPT and Alzheimer disease: Despite being considered as an advanced event in the biological cascade of AD, previous studies suggested that subtle yet characteristic pattern of neurodegeneration could still be detected by FDG PET, CSF total-tau, or MRI at the preclinical or prodromal stage of AD [5–8].